ADV-TK Uses, Dosage, Side Effects and more

ADV-TK is under investigation in clinical trial NCT00638612 (AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)).

Attribute	Details
Trade Name	ADV-TK
Generic	Aglatimagene besadenovec
Aglatimagene besadenovec Other Names	ADV-TK, Aglatimagene besadenovec
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph